Journal of Clinical Oncology, Vol 24, No 14 (May 10), 2006: pp. 2164-2169
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.1656
Genetics, Epidemiology, and Cancer Disparities: Is it Black and White?
Timothy R. Rebbeck,
Chanita Hughes Halbert,
Pamela Sankar
From the Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics; Department of Psychiatry, Abramson Cancer Center; Department of Medical Ethics; Center for Bioethics, University of Pennsylvania School of Medicine, Philadelphia, PA.
Address reprint requests to Timothy R. Rebbeck, PhD, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, 904 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104-6021; e-mail: trebbeck{at}cceb.med.upenn.edu
Epidemiologic studies attempt to understand the distribution and determinants of human disease. Epidemiologic research often incorporates information about race, ethnicity, or ancestry, usually as a self-identified race or ethnicity (SIRE) variable. Differences in the distribution and determinants of disease on the basis of SIRE may be identified in these studies. In addition, genetic and other biologic differences according to SIRE are frequently reported. If these differences are real and meaningful, they may have value in identifying disease-causative or -preventive factors, and thus may be beneficial to human health. However, the concepts of race, ethnicity, or ancestry are often poorly considered or crudely applied, particularly in genetic studies of disease etiology or outcome. Consequently, results suggesting genetic differences with respect to disease etiology or outcome across SIRE groups may not be meaningful; in fact, these differences may prove harmful if they propagate stereotypes or spurious differences. Therefore, it is critical to properly consider the meaning, definitions, and use of race, ethnicity, or ancestry in molecular epidemiologic studies.
Supported by Public Health Service Grants No. P50-CA105641-TRR, DAMD17-00-1-0262-CHH, R01-HG03191-PS, and the University of Pennsylvania Abramson Cancer Center.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Metzger, S. M. Castellino, M. M. Hudson, S. N. Rai, S. C. Kaste, M. J. Krasin, L. E. Kun, C.-H. Pui, and S. C. Howard
Effect of Race on the Outcome of Pediatric Patients With Hodgkin's Lymphoma
J. Clin. Oncol.,
March 10, 2008;
26(8):
1282 - 1288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Raghavan, E. A. Perez, and H. A. Harvey
Disparities in Cancer Care
ASCO Educational Book,
January 1, 2008;
2008(1):
270 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giovannucci, Y. Liu, and W. C. Willett
Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2006;
15(12):
2467 - 2472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Disparities in Cancer Care
J. Oncol. Pract,
September 1, 2006;
2(5):
234 - 239.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. I. Olopade, G. Schwartsmann, N. Saijo, and C. R. Thomas Jr
Disparities in Cancer Care: A Worldwide Perspective and Roadmap for Change
J. Clin. Oncol.,
May 10, 2006;
24(14):
2135 - 2136.
[Full Text]
[PDF]
|
 |
|
|